Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.02 USD | +4.60% | +10.09% | -51.45% |
05-15 | Cabaletta Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | HC Wainwright Adjusts Cabaletta Bio's Price Target to $30 From $25, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.45% | 509M | |
+18.40% | 125B | |
+13.88% | 108B | |
-7.26% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.94% | 16.37B | |
+1.78% | 13.58B | |
+27.67% | 11.66B |
- Stock Market
- Equities
- CABA Stock
- News Cabaletta Bio, Inc.
- HC Wainwright Adjusts Cabaletta Bio's Price Target to $11 From $22, Keeps Buy Rating